Please Note: This trial is no longer enrolling new participants
Fluoroestradiol (FES) PET as a Predictive Measure for Endocrine Therapy in Patients w/ Newly Diagnosed Metastatic Breast Cancer
| Protocol No. | EAI142 | Scope | National |
|---|---|---|---|
| Principal Investigator | Kathy Miller | Treatment Type | Diagnostic |
| Age Group | Adult | Phase | Phase II |
